000 01662 a2200469 4500
005 20250516223149.0
264 0 _c20150420
008 201504s 0 0 eng d
022 _a2211-3436
024 7 _a10.1007/s13402-014-0176-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRask, Lene
245 0 0 _aDifferential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.
_h[electronic resource]
260 _bCellular oncology (Dordrecht, Netherlands)
_cJun 2014
300 _a215-27 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBlotting, Western
650 0 4 _aBreast Neoplasms
_xclassification
650 0 4 _aDown-Regulation
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLymphatic Metastasis
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aPTEN Phosphohydrolase
_xgenetics
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
650 0 4 _aRisk Factors
650 0 4 _aUp-Regulation
700 1 _aBalslev, Eva
700 1 _aSøkilde, Rolf
700 1 _aHøgdall, Estrid
700 1 _aFlyger, Henrik
700 1 _aEriksen, Jens
700 1 _aLitman, Thomas
773 0 _tCellular oncology (Dordrecht, Netherlands)
_gvol. 37
_gno. 3
_gp. 215-27
856 4 0 _uhttps://doi.org/10.1007/s13402-014-0176-6
_zAvailable from publisher's website
999 _c24010307
_d24010307